Usual drug resistance describes isolates that are not fully susceptible wild-type strains but that can nonetheless be readily treated with standard therapies.

UDR is a recently proposed category defining resistance in bacteria which may still be effectively treated with first-line drugs. It may be useful in the context of clinical trials but requires knowledge of first-line drugs within the regional or local context.